Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently, a tyrosine hydroxylase (TH)-expressing CNS-derived cell line,
CAD
, was obtained that is capable of undergoing reversible morphological differentiation. The isolation of the
CAD
line allowed us to ask whether different DNA regulatory elements direct TH transcription when cells are growing and undifferentiated versus postmitotic and differentiated. To this end, we compared expression of a transiently transfected bacterial
chloramphenicol acetyltransferase
reporter gene under the transcriptional control of TH 5' flanking DNA in
CAD
cells grown in the presence and absence of serum. Mutational analysis indicates that
CAD
cells differently regulate TH transcription depending on their state of differentiation. In both states, the cyclic AMP response element and AP1 site each activate transcription. However, in undifferentiated cells, the dyad/E-box element represses expression by approximately 2.7-fold, whereas it modestly activates transcription in differentiated cells. The role of the dyad/ E-box as a repressor correlates well with the two- to threefold lower amount of endogenous TH protein present in the undifferentiated
CAD
cells. This study demonstrates the differential use of TH DNA regulatory elements in proliferating, undifferentiated and nonproliferating, differentiated immortalized neuronal cells.
...
PMID:Differentiation of a catecholaminergic CNS cell line modifies tyrosine hydroxylase transcriptional regulation. 964 50